- Previous Close
10.27 - Open
10.38 - Bid 10.62 x --
- Ask 10.63 x --
- Day's Range
10.32 - 10.74 - 52 Week Range
9.24 - 15.06 - Volume
310,242 - Avg. Volume
241,655 - Market Cap (intraday)
3.492B - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
29.50 - EPS (TTM)
0.36 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 0.42 (3.95%)
- Ex-Dividend Date May 30, 2024
- 1y Target Est
--
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and agriculture, and food. The Catalysis segment provides the business services for propylene and ethylene, syngas and fuels, and specialties. The Adsorbents and Additives segment provides coatings, adhesives and polymer solutions for home care, personal care, coatings, adhesives, agriculture, food, electrics, electronics, automotive, oil, building, construction, aviation, and mining. The company was founded in 1886 and is headquartered in Muttenz, Switzerland.
www.clariant.com10,465
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CLNZ.XC
View MorePerformance Overview: CLNZ.XC
Trailing total returns as of 3/14/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLNZ.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLNZ.XC
View MoreValuation Measures
Market Cap
3.50B
Enterprise Value
5.14B
Trailing P/E
29.50
Forward P/E
10.95
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.84
Price/Book (mrq)
1.60
Enterprise Value/Revenue
1.24
Enterprise Value/EBITDA
9.87
Financial Highlights
Profitability and Income Statement
Profit Margin
5.88%
Return on Assets (ttm)
3.89%
Return on Equity (ttm)
11.94%
Revenue (ttm)
4.15B
Net Income Avi to Common (ttm)
244M
Diluted EPS (ttm)
0.36
Balance Sheet and Cash Flow
Total Cash (mrq)
395M
Total Debt/Equity (mrq)
75.12%
Levered Free Cash Flow (ttm)
98.75M